FDA Inspection
Baxter Healthcare CorporationBaxter Healthcare Corporation – FDA Inspection, Apr 19, 2013
Record Details
This FDA Inspection record concerns Baxter Healthcare Corporation, with an inspection on April 19, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 19, 2013
- Product Type
- Drugs
View Company Profile
ID · 9f6d102e-9956-48a5-92da-688cf2631731
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 832023
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Baxter Healthcare Corporation
13| Date | Classification | Office | Project area |
|---|---|---|---|
| September 29, 2026 | Not classified | San Juan District Office | Drug Quality Assurance |
| July 19, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 30, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 21, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 3, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Baxter Healthcare Corporation
- FDA Inspection 1338220 - 2026-09-29
- FDA Inspection 1240745 - 2024-07-19
- FDA Inspection 1149615 - 2021-07-30
- FDA Inspection 1075479 - 2018-12-21
- FDA Inspection 985599 - 2016-10-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.